Revenue

Chinese tech firm Haivivi launches AI toys that remember and feel, but experts warn of the hidden costs to childhood privacy and development.

A new study reveals why employees are tuning out. It’s not the volume of messages, but a crisis of clarity, trust, and channel fatigue.

With 10,000 Acxiom audiences now live on Amazon DSP, advertisers gain new speed and scale, hinting at a future beyond third-party cookies.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.

ENA Respiratory appoints GSK veteran Melissa Faris to its board, a strategic move signaling an accelerated push for its innovative virus-agnostic nasal spray.

A novel RNA vaccine targeting hidden cancer antigens gets UK approval for a clinical trial, offering new hope for patients with hard-to-treat ovarian cancer.

Parkview Dental Partners' acquisition of a 24/7 Palm Harbor practice signals a major shift in dental care, driven by private equity and patient demand.

The independent wine platform surpasses a major milestone, proving its community-driven, no-sales model is key to empowering a new generation of drinkers.

A new partnership merges rapid modular deployment with concrete's permanence, creating a system that turns wastewater into a profitable, reusable asset.

From the world's best casino to the most lavish lavatory, players are now voting in over 100 categories for the 2026 International Casino Awards.

Facing financial pressures, DBGI Corp. taps a social media star in a high-stakes play to double its $17M NIL fundraising and capture a piece of a $36B market.

Denver-based System76 launches its redesigned Thelio workstations, betting on extreme performance, open-source principles, and user repairability.

Meet the four tech executives vying for the prestigious MIT Sloan CIO Award, exemplifying a new era of strategic, business-driving IT leadership.

With 75% of marketers struggling to understand audiences, Brandwatch's APAC data expansion aims to provide true cultural insight from key Asian platforms.

With FDA clearance, Neuvotion's NeuStim™ platform uses AI and non-invasive stimulation to offer new hope for hand movement after a stroke or spinal injury.

German developer WSCAD brings its ELECTRIX AI platform to the U.S., promising to slash engineering time with AI automation and full U.S. compliance.

Nitinotes' robotic suturing system for weight loss arrives in Spain, promising a new, more accessible era for minimally invasive bariatric procedures.

With a major investment from FTV Capital, fintech firm Valitana is set to accelerate its AI-driven transformation of the complex structured credit world.

With $10M from top VCs, Almanac Health is tackling AI's credibility crisis in medicine with a platform built on evidence, validation, and trust.

Backed by military funding, a novel protein therapy that actively grows bone has finished a key clinical trial, promising to revolutionize dental surgery.